Emphysema

  • Medical Author:
    Charles Patrick Davis, MD, PhD

    Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

  • Medical Editor: George Schiffman, MD, FCCP
    George Schiffman, MD, FCCP

    George Schiffman, MD, FCCP

    Dr. Schiffman received his B.S. degree with High Honors in biology from Hobart College in 1976. He then moved to Chicago where he studied biochemistry at the University of Illinois, Chicago Circle. He attended Rush Medical College where he received his M.D. degree in 1982 and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his Internal Medicine internship and residency at the University of California, Irvine.

Understanding COPD Slideshow Pictures

Quick GuideCOPD Stages, Symptoms, Emphysema, Bronchitis

COPD Stages, Symptoms, Emphysema, Bronchitis

Emphysema facts

  • Emphysema is a destructive disease of the lung in which the alveoli (small sacs) that promote oxygen exchange between the air and the bloodstream are destroyed.
  • Smoking is the primary cause of emphysema, which makes it a preventable illness.
  • There are also less common genetic causes of emphysema including alpha-1 antitrypsin deficiency.
  • The primary symptom of emphysema is shortness of breath. It is a progressive complaint by affected individuals, worsening over time. Early in the disease, shortness of breath may occur with exercise and activity but symptoms gradually worsen and may occur at rest.
  • Diagnosis of emphysema is based upon history, physical examination, and pulmonary function studies.
  • Once present, emphysema is not curable, but its symptoms are controllable.
  • Medication regimens are available to preserve function for daily activities and quality of life for an individual with emphysema.
  • Oxygen supplementation may be required for a person with emphysema.
  • Exercise training and education are essential components of emphysema therapy and pulmonary rehabilitation.
  • Surgical options for individuals with emphysema have been developed and but are not expected to be available for widespread use.
  • Emphysema does not affect quantity of life, but rather quality of life. There are no studies that can predict life-expectancy in individuals with emphysema.

What is emphysema?

Emphysema is a chronic obstructive pulmonary disease (COPD) that presents as an abnormal and permanent enlargement of air spaces distal to the terminal bronchioles. It frequently occurs in association with obstructive pulmonary problems and chronic bronchitis. It is unusual for someone to have pure emphysema unless it is a result of genetic abnormalities. Most people have some combination of emphysema and chronic bronchitis with varying degrees of airway bronchospasm. This condition is commonly referred to as COPD (and in the United Kingdom, as chronic obstructive lung disease, COLD).

There are three morphological types of emphysema; 1) centriacinar, 2) panacinar, and 3) paraseptal.

  1. Centriacinar begins in the respiratory bronchioles and spreads peripherally mainly in the upper half of the lungs and is usually associated with long-standing cigarette smoking.
  2. Panacinar predominates in the lower half of the lungs and destroys the alveolar tissue and is associated with homozygous alpha-1 antitrypsin deficiency, a genetic disease.
  3. Paraseptal emphysema preferentially localizes around the septae of the lungs or pleura, often associated with inflammatory processes, like prior lung infections.

What are the stages of emphysema?

Emphysema staging helps determine how much lung damage is present and how severe it is. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) uses FEV1 measurements to help with this determination:

StageFEV1
I = mildgreater than or equal to 80% predicted
II = moderateless than 80%, greater than 50% predicted
III = severeLess than 50%, greater than 30% predicted
IV = very severeLess than 30% predicted, or less than 50% in chronic respiratory failure
Medically Reviewed by a Doctor on 3/4/2016

Subscribe to MedicineNet's Allergy and Asthma Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

VIEW PATIENT COMMENTS
  • Emphysema - Experience

    Please share your experience with emphysema.

    Post View 33 Comments
  • Emphysema - Symptoms

    What symptoms did you experience with emphysema?

    Post View 18 Comments
  • Emphysema - Risk Factors

    What risk factors do you have for emphysema? If so, what lifestyle changes do you plan to implement to prevent progressive emphysema?

    Post
  • Emphysema - Treatments

    What treatments have been helpful in treating emphysema?

    Post View 3 Comments
  • Emphysema - Diagnosis

    What kinds of tests and exams did you have that led to a diagnosis of emphysema?

    Post View 1 Comment
  • Emphysema - Causes

    If known, what was the cause of your emphysema?

    Post View 2 Comments
  • Emphysema - Smoking

    Are/were you a smoker prior to your emphysema diagnosis? If you've stopped, what worked for you?

    Post View 3 Comments

Health Solutions From Our Sponsors